Mid-term Outcomes of Nissen Fundoplication Versus Roux-en-y Gastric Bypass for Primary Management of Gastroesophageal Reflux Disease in Patients With Obesity

Surg Laparosc Endosc Percutan Tech. 2023 Dec 1;33(6):627-631. doi: 10.1097/SLE.0000000000001215.

Abstract

Introduction: The efficacy and outcomes of laparoscopic Nissen fundoplication (LNF) in patients with obesity is controversial. Specifically, concerns regarding long-term outcomes and recurrence in the setting of obesity has led to interest in laparoscopic Roux-en-Y gastric bypass (RYGB).

Methods: In this retrospective cohort study, we studied patients with obesity who underwent either LNF or RYGB for gastroesophageal reflux disease. Baseline demographics, clinical variables, operative outcomes, and symptom severity scores were compared.

Results: Baseline demographics, operative outcomes, and quality-of-life scores were similar. Proton pump inhibitor usage, quality-of-life, symptom severity scores, and satisfaction with the operation were similar between groups at mid-term follow-up.

Discussion: RYGB and LNF produced similar improvements in disease-specific quality of life with similar rates of complications, side effects, and need for reoperation. This demonstrates that RYGB and LNF represent possible options for surgical management of gastroesophageal reflux disease in obese patients.

MeSH terms

  • Fundoplication
  • Gastric Bypass*
  • Gastroesophageal Reflux* / complications
  • Gastroesophageal Reflux* / surgery
  • Humans
  • Laparoscopy* / adverse effects
  • Obesity / complications
  • Obesity / surgery
  • Quality of Life
  • Retrospective Studies
  • Treatment Outcome